GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
Quote as of Oct 12, 2026 13:38 UTC · Market data delayed approximately 15–20 minutes unless otherwise indicated.
| Previous Close | 86.29 | Day Range | 86.17 – 86.42 |
| 52-Week Range | 70.21 – 92.84 | Volume | 0 |
| Avg Volume | 35.78K | AUM | $1.04B (Oct 12, 2026) |
| Expense Ratio | 0.20% | Yield (TTM) | 1.00% |
| NAV | 85.97 | Premium/Discount | +0.42% indicative |
| Inception | Jun 28, 2017 | Holdings | 1376 |
| Issuer | Goldman | Exchange | AMEX |
| Category | Us Small Cap | Index Tracked | Not stated in source data |
| CUSIP | 381430602 | ISIN | US3814306029 |
| Management | Not stated in source data | ||
About this ETF
This ETF aims to replicate the investment returns generated by the Goldman Sachs ActiveBeta U.S. Small Cap Equity Index.
Description from the fund data provider · profile as of Oct 12, 2026.
Price Chart
Daily closing prices (price return, not total return). Comparison lines are normalized to percent change from the range start. Source: Financial Modeling Prep.
Performance
| 1M | 3M | 6M | YTD | 1Y | 3Y* | 5Y* | 10Y* | Incep.* | |
|---|---|---|---|---|---|---|---|---|---|
| Price return | -2.65% | -4.55% | +10.19% | +14.09% | +15.21% | +15.65% | +6.02% | — | +8.61% |
| Total return | -2.65% | -4.55% | +10.44% | +14.67% | +16.17% | +17.08% | +7.40% | — | +9.95% |
* Annualized. Total return uses the dividend-adjusted price series (distributions reinvested); price return uses unadjusted closes. Performance through Oct 09, 2026. Past performance does not guarantee future results.
Fees
| Net expense ratio | 0.20% | Annual cost of a $10,000 investment | $20.00 |
Illustrative calculation only: expense ratio × $10,000. It excludes trading costs, bid/ask spreads, taxes and changes in investment value. Gross vs. net expense details and any fee waivers are in the prospectus.
Holdings
Holdings as of Oct 11, 2026 · portfolio reporting date from the data provider; holdings are not live positions. 1379 rows in database.
| # | Holding | Ticker | Weight | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | 10X GENOMICS INC | TXG | 0.60% | 81.31K | $6.3M |
| 2 | CAREDX, INC. | CDNA | 0.49% | 82.81K | $5.2M |
| 3 | CMRC/CME EMINIRUS2K 12/2026 | — | 0.48% | 36 | $5.1M |
| 4 | ACADIAN ASSET MANAGEMENT INC | AAMI | 0.34% | 38.37K | $3.6M |
| 5 | ZETA GLOBAL HOLDINGS CORP. | ZETA | 0.32% | 102.37K | $3.4M |
| 6 | ALKERMES PLC | ALKS | 0.32% | 84.12K | $3.4M |
| 7 | TRAVERE THERAPEUTICS, INC. | TVTX | 0.30% | 60.62K | $3.2M |
| 8 | ENOVA INTERNATIONAL, INC. | ENVA | 0.30% | 17.22K | $3.1M |
| 9 | VICTORIA'S SECRET & COMPANY | VSXY | 0.28% | 33.74K | $2.9M |
| 10 | ATRICURE, INC | ATRC | 0.28% | 55.31K | $2.9M |
| 11 | BRIGHTSPRING HEALTH SERVICES, INC. | BTSG | 0.28% | 45.37K | $2.9M |
| 12 | DAVE INC. | DAVE | 0.27% | 8.07K | $2.9M |
| 13 | STONEX GROUP INC. | SNEX | 0.26% | 45.51K | $2.7M |
| 14 | AMNEAL NEWCO INC. | AMRX | 0.26% | 139.08K | $2.7M |
| 15 | ABERCROMBIE & FITCH CO. | ANF | 0.26% | 18.99K | $2.7M |
| 16 | TG THERAPEUTICS, INC. | TGTX | 0.26% | 50.28K | $2.7M |
| 17 | LIGAND PHARMACEUTICALS INCORPORATED | LGND | 0.26% | 9.09K | $2.7M |
| 18 | UMB FINANCIAL CORP | UMBF | 0.26% | 20.47K | $2.7M |
| 19 | ENERSYS | ENS | 0.25% | 14.81K | $2.7M |
| 20 | MOOG INC CL A | MOG-A | 0.24% | 7.04K | $2.6M |
| 21 | UNITED NATURAL FOODS INC | UNFI | 0.24% | 57.47K | $2.5M |
| 22 | VIASAT, INC | VSAT | 0.24% | 37.54K | $2.5M |
| 23 | PACIRA BIOSCIENCES INC | PCRX | 0.24% | 69.45K | $2.5M |
| 24 | GLAUKOS CORPORATION | GKOS | 0.24% | 15.51K | $2.5M |
| 25 | BIOCRYST PHARMACEUTICALS INC | BCRX | 0.23% | 292.81K | $2.4M |
Click a ticker to see every ETF that owns it.
Sector Exposure
Geographic Exposure
Country weights as reported by the data provider. Developed/emerging/frontier labels follow the classification on the Methodology page. Currency hedged: No hedging indicated in the fund name.
Distributions
| Yield (TTM) | 1.00% | Paid (last 12 months) | $0.8640 |
| Frequency | Quarterly | SEC yield | Not provided by our data source; see the issuer page |
| Last ex-date | Sep 24, 2026 | Last payment | $0.1975 (Sep 30, 2026) |
| Growth 1Y | -19.86% | Growth 3Y / 5Y (ann.) | +1.55% / +12.34% |
| Ex-date | Record | Pay date | Amount |
|---|---|---|---|
| Sep 24, 2026 | Sep 24, 2026 | Sep 30, 2026 | $0.1975 |
| Jun 24, 2026 | Jun 24, 2026 | Jun 30, 2026 | $0.2142 |
| Mar 25, 2026 | Mar 25, 2026 | Mar 31, 2026 | $0.2049 |
| Dec 23, 2025 | Dec 23, 2025 | Dec 30, 2025 | $0.2474 |
| Sep 24, 2025 | Sep 24, 2025 | Sep 30, 2025 | $0.2712 |
| Jun 24, 2025 | Jun 24, 2025 | Jun 30, 2025 | $0.1943 |
| Mar 25, 2025 | Mar 25, 2025 | Mar 31, 2025 | $0.1755 |
| Dec 23, 2024 | Dec 23, 2024 | Dec 30, 2024 | $0.4371 |
| Sep 24, 2024 | Sep 24, 2024 | Sep 30, 2024 | $0.1164 |
| Jun 24, 2024 | Jun 24, 2024 | Jun 28, 2024 | $0.2301 |
| Mar 22, 2024 | Mar 25, 2024 | Mar 28, 2024 | $0.1959 |
| Dec 26, 2023 | Dec 27, 2023 | Jan 02, 2024 | $0.3146 |
Trailing distribution yield = last 12 months of cash ÷ current price. It is NOT the SEC 30-day yield and distributions are not guaranteed to continue. The difference explained →
Risk Statistics
| Volatility 1Y / 3Y | 17.41% / 20.34% | Sharpe 1Y / 3Y | 1.04 / 0.807 |
| Max drawdown 1Y / 3Y | -10.56% / -26.05% | Sortino 1Y | 1.58 |
| Beta vs S&P 500 (3Y) | 1.05 | Correlation vs S&P 500 (1Y) | 0.794 |
| Downside deviation 1Y | 11.45% | Risk-free rate used | 4.05% (3M T-bill, FRED) |
Computed by ETF Explorer from daily dividend-adjusted closes; volatility and drawdown are annualized/period figures; S&P 500 exposure proxied by SPY. As of Oct 12, 2026. Formulas →
Liquidity
| Volume today | 0 | Average volume | 35.78K |
| AUM | $1.04B | Premium/Discount | +0.42% |
| Bid/Ask spread | Not provided by our data source. Check your broker's quote screen; spreads are widest at the open and close. | ||
Premium/discount compares the delayed market price with the last reported NAV: an indicative figure, not the official closing premium/discount. How ETF liquidity works →
Fund Flows (estimated)
| Period | Est. net flow | % of starting AUM | AUM start → end |
|---|---|---|---|
| 1 Day | $0.00 | 0.00% | $1.04B → $1.04B |
| 1 Month | $12.0M | +1.13% | $1.06B → $1.04B |
| 1 Week | $12.1M | +1.16% | $1.05B → $1.04B |
ETF Explorer estimate: change in reported AUM minus the market-move effect, from our own daily snapshots. Not official issuer creation/redemption data.
Official Fund Resources
External links open the issuer's site or SEC EDGAR in a new tab. The prospectus and official documents are always the authoritative source; review them before investing.
Latest News for GSSC
No articles mention this fund directly in the last 7 days; showing general ETF coverage.
Guided help: AUM is fund size. The expense ratio is the yearly cost baked into returns. NAV is the value of what the fund owns per share; the market price can sit slightly above (premium) or below (discount) it. Total return assumes distributions were reinvested. Every dataset shows its own as-of date because holdings, assets and quotes update on different schedules.